On May 27, 2022,
IMMUNOBIO laboratory successfully developed monkeypox recombinant antigen. As soon as the raw material products were launched, orders were received from various experiments across the country.
At present, the finished product has also been prepared and obtained the CE certificate.
Post time:Jun-15-2022
Post time: 2023-11-16 21:50:44